Sumitomo Pharma America logo

Sumitomo Pharma America

Healthcare

About

Sumitomo Pharma America (SMPA) is a U.S.-based biopharmaceutical company that leverages science and technology to develop innovative therapies for high‑unmet‑need areas, including oncology, urology, women’s health, rare diseases, cell and gene therapies, and central nervous system disorders. By integrating the expertise and pipelines of former Sumitomo Pharma affiliates—Sunovion, Sumitomo Pharma Oncology, Sumitovant, Myovant, Urovant, and Enzyvant—SMPA accelerates drug discovery, development, and commercialization. SMPA’s core value proposition is delivering breakthrough treatments that address critical patient needs while offering a collaborative, research‑driven environment for professionals seeking to advance their careers in cutting‑edge biopharma.

Share feedback - DM or email [email protected]
© 2026 Hirebase. All rights reserved.